{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:06:09Z","timestamp":1778717169758,"version":"3.51.4"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,12]]},"DOI":"10.18632\/oncotarget.8018","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T11:05:25Z","timestamp":1457607925000},"page":"20801-20809","source":"Crossref","is-referenced-by-count":19,"title":["EphA8 is a prognostic marker for epithelial ovarian cancer"],"prefix":"10.18632","volume":"7","author":[{"given":"Xiaoqin","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nursing, Nantong University, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuquan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xujuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nursing, Nantong University, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","article-title":"An international assessment of ovarian cancer incidence and mortality","volume":"130","author":"Goff","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7314\/APJCP.2014.15.1.191","article-title":"Time trends of ovarian cancer incidence in China","volume":"15","author":"Sun","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4331\/wjbc.v5.i3.286","article-title":"In 2014, can we do better than CA125 in the early detection of ovarian cancer?","volume":"5","author":"Farias-Eisner","year":"2014","journal-title":"World J Biol Chem"},{"key":"4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Jacobs","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajco.12449","article-title":"Frontline treatment of epithelial ovarian cancer","volume":"11","author":"Baron-Hay","year":"2015","journal-title":"Asia Pac J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12935-015-0267-0","article-title":"Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives","volume":"15","author":"Kimura","year":"2015","journal-title":"Cancer Cell Int"},{"key":"7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/bjc.2015.394","article-title":"The development of PARP inhibitors in ovarian cancer: from bench to bedside","volume":"113","author":"Drew","year":"2015","journal-title":"Br J Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1067\/S0002-9378(03)00579-9","article-title":"Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades","volume":"189","author":"Munkarah","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"9","first-page":"5","article-title":"Eph receptor signaling and ephrins","author":"Pasquale","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ceb.2007.08.004","article-title":"Cell-cell signaling via Eph receptors and ephrins","volume":"19","author":"Nikolov","year":"2007","journal-title":"Curr Opin Cell Biol"},{"key":"11","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbapap.2013.04.020","article-title":"Eph\/ephrin recognition and the role of Eph\/ephrin clusters in signaling initiation","volume":"1834","author":"Himanen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.semcdb.2011.10.014","article-title":"Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling","volume":"23","author":"Brantley-Sieders","year":"2012","journal-title":"Semin Cell Dev Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-014-1618-8","article-title":"EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma","volume":"121","author":"MacDonald","year":"2015","journal-title":"J Neurooncol"},{"key":"14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10555-012-9352-1","article-title":"The Eph\/Ephrin family in cancer metastasis: communication at the service of invasion","volume":"31","author":"Kandouz","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"15","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1101\/gad.1973910","article-title":"Eph\/ephrin molecules\u2014a hub for signaling and endocytosis","volume":"24","author":"Adams","year":"2010","journal-title":"Genes Dev"},{"key":"16","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1038\/sj.onc.1208584","article-title":"The EphA8 receptor induces sustained MAP kinase activation to promote neurite outgrowth in neuronal cells","volume":"24","author":"Park","year":"2005","journal-title":"Oncogene"},{"key":"17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/dneu.22092","article-title":"Expression of EphA8-Fc in transgenic mouse embryos induces apoptosis of neural epithelial cells during brain development","volume":"73","author":"Park","year":"2013","journal-title":"Dev Neurobiol"},{"key":"18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1373\/clinchem.2003.026849","article-title":"Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers","volume":"50","author":"Vogt","year":"2004","journal-title":"Clin Chem"},{"key":"19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.febslet.2015.02.005","article-title":"miR-10a controls glioma migration and invasion through regulating epithelial-mesenchymal transition via EphA8","volume":"589","author":"Yang","year":"2015","journal-title":"FEBS Lett"},{"key":"20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/jclinpath-2015-203160","article-title":"Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival","volume":"69","author":"Wang","year":"2016","journal-title":"J Clin Pathol"},{"key":"21","first-page":"313","article-title":"Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"22","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-13-0159","article-title":"Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment","volume":"3","author":"Almeida","year":"2013","journal-title":"Cancer Discov"},{"key":"23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4161\/epi.2.4.5406","article-title":"The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers","volume":"2","author":"Suo","year":"2007","journal-title":"Epigenetics"},{"key":"24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjc.6604216","article-title":"Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers","volume":"98","author":"Tamaya","year":"2008","journal-title":"Br J Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.humpath.2006.02.021","article-title":"Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis","volume":"37","author":"Ramon y Cajal","year":"2006","journal-title":"Hum Pathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2407-6-144","article-title":"Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival","volume":"6","author":"Boyd","year":"2006","journal-title":"BMC Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.2825356","article-title":"A novel putative tyrosine kinase receptor encoded by the eph gene","volume":"238","author":"Takaku","year":"1987","journal-title":"Science"},{"key":"29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/368558a0","article-title":"B61 is a ligand for the ECK receptor protein-tyrosine kinase","volume":"368","author":"Guthrie","year":"1994","journal-title":"Nature"},{"key":"30","first-page":"445","article-title":"Overexpression confers an oncogenic potential upon the eph gene","volume":"5","author":"Takaku","year":"1990","journal-title":"Oncogene"},{"key":"31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2407-9-237","article-title":"Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26. 2-q29 in squamous cell carcinoma of the lung","volume":"9","author":"Kim","year":"2009","journal-title":"BMC Cancer"},{"key":"32","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1158\/0008-5472.CAN-05-1855","article-title":"Somatic mutations of the protein kinase gene family in human lung cancer","volume":"65","author":"Avis","year":"2005","journal-title":"Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Zhang","year":"2008","journal-title":"Nature"},{"key":"34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2004.09.002","article-title":"The role of ephrins and Eph receptors in cancer","volume":"15","author":"Salgia","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/bjc.2014.73","article-title":"Eph receptors as therapeutic targets in glioblastoma","volume":"111","author":"Boyd","year":"2014","journal-title":"Br J Cancer"},{"key":"36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/08977194.2014.982276","article-title":"EphA3 biology and cancer","volume":"32","author":"Vail","year":"2014","journal-title":"Growth Factors"},{"key":"37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-386503-8.00001-6","article-title":"Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases","volume":"114","author":"Chen","year":"2012","journal-title":"Adv Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5732\/cjc.013.10108","article-title":"The role of EPH receptors in cancer-related epithelial-mesenchymal transition","volume":"33","author":"Chen","year":"2014","journal-title":"Chin J Cancer"},{"key":"39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/geno.1996.4569","article-title":"ECK, a human EPH-related gene, maps to 1p36. 1, a common region of alteration in human cancers","volume":"40","author":"Ikegaki","year":"1997","journal-title":"Genomics"},{"key":"40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng1408","article-title":"Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer","volume":"36","author":"Elkahloun","year":"2004","journal-title":"Nat Genet"},{"key":"41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12885-015-1025-3","article-title":"Downregulation of EphA5 by promoter methylation in human prostate cancer","volume":"15","author":"Li","year":"2015","journal-title":"BMC Cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2009-05-222208","article-title":"Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia","volume":"115","author":"Garcia-Manero","year":"2010","journal-title":"Blood"},{"key":"43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.humpath.2009.06.007","article-title":"Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer","volume":"41","author":"Shao","year":"2010","journal-title":"Hum Pathol"},{"key":"44","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ng.2007.11","article-title":"EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells","volume":"39","author":"Sancho","year":"2007","journal-title":"Nat Genet"},{"key":"45","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1093\/emboj\/16.11.3106","article-title":"Aberrant axonal projections in mice lacking EphA8 (Eek) tyrosine protein kinase receptors","volume":"16","author":"Barbacid","year":"1997","journal-title":"EMBO J"},{"key":"46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0959-4388(98)80015-9","article-title":"Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta","volume":"8","author":"Schlessinger","year":"1998","journal-title":"Curr Opin Neurobiol"},{"key":"47","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1128\/MCB.21.14.4579-4597.2001","article-title":"The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner","volume":"21","author":"Park","year":"2001","journal-title":"Mol Cell Biol"},{"key":"48","doi-asserted-by":"crossref","first-page":"12104","DOI":"10.1038\/srep12104","article-title":"Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer","volume":"5","author":"Huang","year":"2015","journal-title":"Sci Rep"},{"key":"49","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.48.9.876","article-title":"A \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas","volume":"48","author":"Dowsett","year":"1995","journal-title":"J Clin Pathol"},{"key":"50","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1038\/srep12991","article-title":"High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"51","doi-asserted-by":"publisher","first-page":"24912","DOI":"10.18632\/oncotarget.4701","article-title":"Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:08:23Z","timestamp":1589224103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":51,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2016,4,12]]}},"alternative-id":["8018","26989075"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8018","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]}}}